KQ Labs launched with its first cohort in 2018. Find out more about the companies who have taken part in the accelerator.
CSS amends
Cohort 6: 2023-2024
Beautiful Voice
Beautiful Voice employs AI and gamification to modernise speech and language therapy delivery, making high-quality speech and language therapy more accessible, efficient and data-driven for patients, speech and language therapists and caregivers
Juniver is transforming the $66bn eating disorder market through a first-of-its-kind platform shown to be 92% effective in a pilot and designed to cover the full continuum of care, from self-guided experiences proven to drive symptom reduction to a 1:1 virtual clinic.
Increasing representation of minority groups (women, black and ethnic minorities) in pre-clinical research and clinical trials by the appropriate amount according to diseases such as breast cancer, which promotes drug characterisation and improves drug efficacy and safety in these groups.
CardiaTec is a University of Cambridge spin-out, pioneering in cardiovascular drug discovery with its AI-driven multi-omics drug target discovery platform.
Cytecom is on a mission to fight antimicrobial resistance (AMR) by electrocuting bacteria to detect live cells and provide AMR profiles at point-of-care, informing the correct targeted antimicrobial therapy sooner than any other test.
One test: infinite insights. StoreGene's clinical genomic operating system enables rapid translation of genetic research to genome insights for data-driven precision medicine.
Strolll develops digital therapeutics (DTx) software for augmented reality glasses that empowers movement therapy for people living with neurological disorders.
Concinnity Genetics is improving the safety and efficacy of gene therapies using AI.
Diabetech
Diabetech is the next generation digital product for behaviour change in chronic health conditions such as diabetes.
They offer behavioural rewards and behavioural coaching to increase adherence rates and help diabetics better manage their condition.
Proton Health is a full-stack solution using patient-reported data, machine learning and personalised coaching to predict and prevent eczema flare-ups.
Enedra is checkmating cancer’s best moves by creating a new generation of drugs that target tumour evolution and heterogeneity using synthetic lethality and AI.
Exogene enables the discovery of T-cell receptor (TCR)-based cell therapies to cure advanced solid cancers, by combining AI and high throughput TCR screening in the lab.
Anya is an award-winning start-up using cutting-edge 3D interactive technology and artificial intelligence to support current and future parents through the breastfeeding and parenthood journey 24/7.
Lindus Health's mission is to accelerate research for the next generation of healthcare companies.
They are building the world’s first full stack clinical trial platform to conduct faster, safer clinical trials, improving health outcomes for everyone.
MultiplAI is developing universal genomic screening for cardiovascular diseases using RNA sequencing and machine learning.
Bringing liquid biopsy to cardiovascular disease diagnosis enables a breakthrough in access to preventative care and precise prognosis for anyone on the planet.
NeuroVirt is a medtech company that uses virtual reality (VR) and in-house hardware to gamify rehabilitation for post-stroke patients and quantify measurements of hand impairment and improvement for doctors.
Benetalk has developed a digital speech therapist that monitors speaking patterns and provides immediate feedback to help people who stutter to master fluency speaking habits during daily activities.
Brightlobe develops cutting-edge technology that can intelligently assess and support a child’s developmental trajectory through mobile games and smart toys.
Charco Neurotech have developed CUE1, a non-invasive wearable device for Parkinson’s, utilising pulsed cueing and focused vibrotactile stimulation to reduce symptoms of slowness and stiffness resulting in improved movement.
GLAMOROUS AI has a novel approach to chemical design and optimisation. Its proprietary platform, Rosalind, augments advanced ML with human expertise to enable applications where only limited data points are available.
Little Journey use technology, research and data to transform healthcare and research outcomes through an end to end psychological preparation and support tool for children and their families.
Oxford Cancer Analytics aims to revolutionise early cancer detection and treatment through affordable blood tests using automated machine learning platforms for data analysis, biomarker discovery and patient stratification.
Baseimmune is a company created to offer data-driven solutions to vaccine design. Our mission is to monitor and integrate big-data on genomics, proteomics, as well as geographical and clinical data into antigen discovery and vaccine development.
Bold Health is a digital therapeutic platform leveraging behavioural medicine and data science to create personalised care programs for the self-management of chronic digestive conditions.
Jiva.ai is a machine learning platform that puts model integration at the centre of its data science workflow and is currently engaged in identification and diagnosis of prostate cancer from MRI scans.
Oppilotech developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the platform to identify first-in-class drug targets and develop drugs that modulate them.
Pexxi is a precision medicine platform, matching women with the optimal oral contraceptives based on their medical history, hormone levels and genetic profile.
Sano Genetics is a platform for personalised medicine that connects people with relevant research studies and clinical trials based on their genetic and health data.
Zetta Genomics provides the big data foundation for generation genome. Our distributed storage and analysis technology provides the quality and convenience needed to move genomics from research to medicine at scale.
Head injuries are the leading cause of death and disability among the under 45s. Cortirio are developing portable brain imaging to diagnose head injuries at the point of care.
Deepscope is the first free ultrasound simulator for mobile devices. It enables healthcare professionals both to learn, using the free mobile app, and to teach, by easily creating their own clinical simulations.
Heron have created a graphical and navigable map of science, helping researchers, clinicians and industry gain more value from scientific literature.
Macusoft
Macular disease is the biggest cause of preventable sight loss in the developed world. Macusoft is developing clinical data and genomics based AI systems to support treatment to prevent avoidable blindness.
Vesynta personalizes dosing of life-saving therapies through a desktop blood monitoring lab for rapid drug quantification, advancing medicines optimization and patient health outcomes.